lysine has been researched along with actinonin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansorge, S; Bank, U; Faust, J; Fuchs, P; Heimburg, A; Helmuth, M; Lendeckel, U; Neubert, K; Reinhold, D; Sens, B; Stefin, S; Täger, M | 1 |
| Ansorge, S; Bank, U; Biton, A; Brocke, S; Faust, J; Lendeckel, U; Neubert, K; Pieper, S; Reinhold, D; Täger, M | 1 |
| Ansorge, S; Bank, U; Biton, A; Brocke, S; Reinhold, D; Täger, M | 1 |
3 other study(ies) available for lysine and actinonin
| Article | Year |
|---|---|
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Topics: Animals; Body Weight; CD13 Antigens; Colitis; Colon; Cytokines; Dextran Sulfate; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Forkhead Transcription Factors; Gene Expression; Hydroxamic Acids; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lysine; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta | 2006 |
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Topics: Animals; Antibodies; CD13 Antigens; Cell Proliferation; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Hydroxamic Acids; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocyte Activation; Lysine; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Peptide Fragments; Phytohemagglutinins; Pokeweed Mitogens; Protease Inhibitors; Pyrrolidines; T-Lymphocytes; Thiazoles; Transforming Growth Factor beta1; Vaccination | 2006 |
Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
Topics: Animals; CD13 Antigens; CD4-Positive T-Lymphocytes; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Dipeptidyl Peptidase 4; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Lymphocyte Activation; Lysine; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pyrroles; Pyrrolidines; Thiazoles; Transgenes | 2011 |